Johnson & Johnson (JNJ) has halted its late-stage Covid-19 vaccine trial after a study participant fell ill, news provider STAT has reported. The details of the ‘unexplained illness’ have not been provided.“We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” JNJ told STAT in a statement.A document sent to researchers running the 60,000-patient clinical trial, and obtained by STAT, revealed that a “pausing rule” had been met, and as a result the online enrollment system was closed and an independent safety committee …read more
Source:: Yahoo Finance
